Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 2Thoracic 1Other solid neoplasm 1Gynecologic 1Genitourinary 1Gastrointestinal 1

Conditions

Lung Neoplasms 2Thymoma 1Small Cell Lung Carcinoma 1Pancreatic Neoplasms 1Metastatic Solid Tumors 1Mesothelioma, Malignant 1Mesothelioma 1Kidney Neoplasms 1Esophageal Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1

Interventions

pembrolizumab 6belinostat 2Pemetrexed 2Cyclophosphamide 2Cisplatin 2Carboplatin 2tocilizumab 1sargramostim 1ribociclib 1rebastinib 1enzalutamide 1entinostat 1durvalumab 1cemiplimab 1avelumab 1atezolizumab 1abemaciclib 1Valacyclovir 1Surgical Procedures, Operative 1Sorafenib 1Sirolimus 1Quality of Life 1Psychiatric Rehabilitation 1Polymerase Chain Reaction 1Plicamycin 1Patient Reported Outcome Measures 1Nivolumab 1Molecular Diagnostic Techniques 1Midazolam 1Microarray Analysis 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Breast Neoplasms × FANG vaccine × Other solid neoplasm × Clear all
NCT00002475 2013-07-10

Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer

National Cancer Institute (NCI)

Phase 2 Completed
40 enrolled
BreastGastrointestinalGenitourinaryOther solid neoplasmThoracic

Mesothelioma, Malignant, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Colonic Neoplasms, Kidney Neoplasms, Lung Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡